Eli Lilly and Company (LLY.DE)

EUR 739.3

(12.41%)

Operating Income Summary of Eli Lilly and Company

  • Eli Lilly and Company's latest annual operating income in 2023 was 6.98 Billion USD , up 53.33% from previous year.
  • Eli Lilly and Company's latest quarterly operating income in 2024 Q2 was 4.41 Billion USD , up 61.52% from previous quarter.
  • Eli Lilly and Company reported an annual operating income of 7.12 Billion USD in 2022, up 12.12% from previous year.
  • Eli Lilly and Company reported an annual operating income of 6.35 Billion USD in 2021, up 4.94% from previous year.
  • Eli Lilly and Company reported a quarterly operating income of 4.43 Billion USD for 2024 Q3, up 0.36% from previous quarter.
  • Eli Lilly and Company reported a quarterly operating income of 2.73 Billion USD for 2024 Q1, down -14.94% from previous quarter.

Annual Operating Income Chart of Eli Lilly and Company (2023 - 1989)

Historical Annual Operating Income of Eli Lilly and Company (2023 - 1989)

Year Operating Income Operating Income Growth
2023 6.98 Billion USD 53.33%
2022 7.12 Billion USD 12.12%
2021 6.35 Billion USD 4.94%
2020 6.05 Billion USD 21.79%
2019 4.97 Billion USD -19.6%
2018 6.18 Billion USD 188.43%
2017 2.14 Billion USD -37.98%
2016 3.45 Billion USD 28.61%
2015 2.68 Billion USD 1.11%
2014 2.65 Billion USD -50.47%
2013 5.37 Billion USD 13.44%
2012 4.73 Billion USD -14.37%
2011 5.52 Billion USD -18.36%
2010 6.77 Billion USD 6.31%
2009 6.37 Billion USD 15.23%
2008 5.52 Billion USD 15.1%
2007 4.8 Billion USD 16.42%
2006 4.12 Billion USD 13.07%
2005 3.64 Billion USD -0.28%
2004 3.65 Billion USD 4.48%
2003 3.5 Billion USD 5.23%
2002 3.32 Billion USD -10.78%
2001 3.72 Billion USD 4.78%
2000 3.55 Billion USD 5.83%
1999 3.36 Billion USD 19.09%
1998 2.82 Billion USD 14.9%
1997 2.45 Billion USD 20.1%
1996 2.04 Billion USD 3.28%
1995 1.98 Billion USD 10.41%
1994 1.79 Billion USD 175.04%
1993 652.6 Million USD -43.52%
1992 1.15 Billion USD -34.65%
1991 1.76 Billion USD 14.87%
1990 1.53 Billion USD 32.16%
1989 1.16 Billion USD 11.27%

Peer Operating Income Comparison of Eli Lilly and Company

Name Operating Income Operating Income Difference
Bayer Aktiengesellschaft -150 Million EUR 4758.333%
Sanofi 7.87 Billion EUR 11.27%